{"id":"alteplase-for-injection","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Hemorrhage"},{"rate":"1-5%","effect":"Allergic reactions"},{"rate":"1-5%","effect":"Hypotension"},{"rate":"0.1-1%","effect":"Cardiac arrest"},{"rate":"0.1-1%","effect":"Respiratory arrest"}]},"_chembl":{"chemblId":"CHEMBL1201593","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by converting plasminogen into plasmin, which then breaks down fibrin clots. This process helps to restore blood flow in conditions such as ischemic stroke.","oneSentence":"Alteplase for Injection is a tissue plasminogen activator that works by dissolving blood clots.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:08:23.036Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ischemic stroke"},{"name":"Acute ischemic stroke"}]},"trialDetails":[{"nctId":"NCT06018181","phase":"","title":"Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2023-09-28","conditions":"Ischemic Stroke, Acute","enrollment":2408},{"nctId":"NCT04663750","phase":"PHASE3","title":"Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2021-04-16","conditions":"Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage","enrollment":210},{"nctId":"NCT07201688","phase":"PHASE3","title":"Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.","status":"RECRUITING","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-30","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT07047014","phase":"PHASE3","title":"Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-30","conditions":"Stroke, Ischemic, Medium Vessel Occlusions","enrollment":596},{"nctId":"NCT06954155","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-30","conditions":"Stroke","enrollment":330},{"nctId":"NCT05797792","phase":"PHASE3","title":"CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-11-18","conditions":"Stroke, Acute Ischemic, Stroke, Acute","enrollment":440},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT03187405","phase":"PHASE3","title":"Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage.","status":"TERMINATED","sponsor":"University Hospital, Caen","startDate":"2018-02-21","conditions":"Subarachnoid Hemorrhage","enrollment":81},{"nctId":"NCT04920448","phase":"PHASE2","title":"N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE","status":"TERMINATED","sponsor":"University Hospital, Caen","startDate":"2021-06-16","conditions":"Stroke, Ischemic","enrollment":12},{"nctId":"NCT03151993","phase":"PHASE3","title":"Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2017-03-18","conditions":"Ischemic Stroke","enrollment":336},{"nctId":"NCT04688320","phase":"PHASE3","title":"Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2020-12-15","conditions":"Massive Pulmonary Embolism","enrollment":310},{"nctId":"NCT02301910","phase":"PHASE3","title":"Single Bolus Recombinant Nonimmunogenic Staphylokinase Versus Single Bolus Tenecteplase (Metalyse) in STEMI","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2014-05-16","conditions":"Myocardial Infarction","enrollment":382},{"nctId":"NCT06668441","phase":"PHASE1","title":"Minimally Invasive Surgery and RhTNK-tPA for Intracerebral Hemorrhage Evacuation","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-11-04","conditions":"Intracranial Hemorrhages, Cerebrovascular Disorders, Cerebral Hemorrhage","enrollment":12},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT04088292","phase":"PHASE3","title":"Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-06","conditions":"Pulmonary Embolism","enrollment":210},{"nctId":"NCT06667882","phase":"NA","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-12-17","conditions":"Pulmonary Embolism Subacute Massive, Complication of Treatment, Fibrinolysis; Hemorrhage","enrollment":33},{"nctId":"NCT03998319","phase":"PHASE3","title":"A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-10-14","conditions":"STEMI, Elevated IMR (>32)","enrollment":445},{"nctId":"NCT06487052","phase":"NA","title":"Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2024-01-10","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT03785678","phase":"PHASE3","title":"Tenecteplase in Stroke Patients Between 4.5 and 24 Hours","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2019-03-02","conditions":"THROMBOLYSIS","enrollment":458},{"nctId":"NCT05295173","phase":"PHASE3","title":"A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）","status":"COMPLETED","sponsor":"Angde Biotech Pharmaceutical Co., Ltd.","startDate":"2022-03-21","conditions":"Acute Ischemic Stroke","enrollment":1412},{"nctId":"NCT05188417","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"GrandPharma (China) Co., Ltd.","startDate":"2021-12-09","conditions":"Acute Ischemic Stroke","enrollment":266},{"nctId":"NCT04797013","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2021-06-12","conditions":"Acute Ischemic Stroke","enrollment":1430},{"nctId":"NCT05626972","phase":"PHASE3","title":"Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy","status":"UNKNOWN","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2022-05-27","conditions":"Acute Ischemic Stroke","enrollment":500},{"nctId":"NCT05580822","phase":"PHASE2","title":"Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion","status":"UNKNOWN","sponsor":"First Hospital of China Medical University","startDate":"2023-01-01","conditions":"Basilar Artery Occlusion, Thrombectomy, Tenecteplase","enrollment":520},{"nctId":"NCT03876119","phase":"PHASE2, PHASE3","title":"Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2018-12-05","conditions":"Stroke, Acute","enrollment":121},{"nctId":"NCT04071613","phase":"PHASE2","title":"Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2019-06-20","conditions":"Stroke, Acute, Stroke Ischemic","enrollment":104},{"nctId":"NCT04978181","phase":"","title":"The Prevalence and Associated Factors of Early Deterioration After Successful Recanalization in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-08-01","conditions":"Acute Stroke","enrollment":30},{"nctId":"NCT03988842","phase":"PHASE4","title":"Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism","status":"TERMINATED","sponsor":"Victor Tapson, MD","startDate":"2019-07-25","conditions":"Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism, Pulmonary Embolism With Pulmonary Infarction","enrollment":4},{"nctId":"NCT03394950","phase":"PHASE4","title":"Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Hui-Sheng Chen","startDate":"2018-05-25","conditions":"Stroke, Ischemic","enrollment":120},{"nctId":"NCT03181360","phase":"PHASE3","title":"Tenecteplase in Wake-up Ischaemic Stroke Trial","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2017-06-12","conditions":"Ischemic Stroke, Stroke, Acute","enrollment":600},{"nctId":"NCT02685995","phase":"NA","title":"VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2015-12","conditions":"Renal Failure Chronic Requiring Hemodialysis, Chronic Renal Insufficiency","enrollment":100},{"nctId":"NCT04676659","phase":"PHASE2","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2018-05-12","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT03348826","phase":"PHASE2","title":"Study of Sodium Bicarbonate in Restoring Blocked Catheters","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2020-06-01","conditions":"Cancer, Central Venous Catheterization","enrollment":""},{"nctId":"NCT03357133","phase":"PHASE2, PHASE3","title":"Tirofiban for Patients Treated With Alteplase","status":"TERMINATED","sponsor":"Capital Medical University","startDate":"2017-12-16","conditions":"Ischemic Stroke","enrollment":30},{"nctId":"NCT01835067","phase":"PHASE2, PHASE3","title":"Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD","status":"COMPLETED","sponsor":"King's College Hospital NHS Trust","startDate":"2014-09","conditions":"Exudative Macular Degeneration, Retinal Hemorrhage","enrollment":55},{"nctId":"NCT02618031","phase":"PHASE1","title":"The Capillary Index Score Trial","status":"COMPLETED","sponsor":"Firas Al-Ali","startDate":"2016-03-01","conditions":"Acute Stroke, Brain Ischemia, Ischemic Stroke","enrollment":57},{"nctId":"NCT04110275","phase":"PHASE2","title":"Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)","status":"UNKNOWN","sponsor":"Angde Biotech Pharmaceutical Co., Ltd.","startDate":"2019-10","conditions":"Acute Pulmonary Embolism","enrollment":174},{"nctId":"NCT04028518","phase":"PHASE2","title":"A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.","status":"UNKNOWN","sponsor":"Angde Biotech Pharmaceutical Co., Ltd.","startDate":"2019-07-20","conditions":"Acute Ischemic Stroke","enrollment":180},{"nctId":"NCT03997292","phase":"","title":"Intravenous Thrombolysis Registry for Acute Ischemic Stroke in China","status":"WITHDRAWN","sponsor":"General Hospital of Shenyang Military Region","startDate":"2018-03-01","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT03098732","phase":"NA","title":"Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial","status":"SUSPENDED","sponsor":"Pulse Therapeutics","startDate":"2017-03-22","conditions":"Stroke, Acute, Stroke, Ischemic, Infarction, Middle Cerebral Artery","enrollment":120},{"nctId":"NCT01581411","phase":"PHASE1","title":"Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2012-01","conditions":"Central Retinal Vein Occlusion","enrollment":1},{"nctId":"NCT02338466","phase":"PHASE2","title":"Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion","status":"WITHDRAWN","sponsor":"University Hospital Center of Martinique","startDate":"2016-07","conditions":"Nervous System Disorders, Cerebral Artery","enrollment":""},{"nctId":"NCT02135926","phase":"NA","title":"Thrombectomy in Patients Ineligible for iv tPA","status":"TERMINATED","sponsor":"University Hospital Heidelberg","startDate":"2014-03","conditions":"Ischemic Stroke","enrollment":4},{"nctId":"NCT01930682","phase":"PHASE4","title":"EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction","status":"COMPLETED","sponsor":"RenJi Hospital","startDate":"2014-01-13","conditions":"Acute ST-segment Elevation Myocardial Infarction","enrollment":344},{"nctId":"NCT01062698","phase":"NA","title":"Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke","status":"TERMINATED","sponsor":"Central Hospital, Nancy, France","startDate":"2010-06","conditions":"Cerebral Stroke, Cerebrovascular Accident","enrollment":412},{"nctId":"NCT01643902","phase":"PHASE2","title":"Safety of Intravenous Thrombolytics in Stroke on Awakening","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-01","conditions":"Stroke","enrollment":20},{"nctId":"NCT01222117","phase":"PHASE2","title":"A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2010-12","conditions":"Acute Peripheral Arterial Occlusion","enrollment":174},{"nctId":"NCT01678495","phase":"PHASE2","title":"Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2012-08","conditions":"Cerebrovascular Stroke","enrollment":24},{"nctId":"NCT00284739","phase":"PHASE2","title":"Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2006-02","conditions":"Abdominal Abscess, Pelvic Abscess","enrollment":20},{"nctId":"NCT01580618","phase":"PHASE2, PHASE3","title":"Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy","status":"TERMINATED","sponsor":"Kaiser Permanente","startDate":"2008-01","conditions":"Pleural Effusion","enrollment":20},{"nctId":"NCT00082355","phase":"PHASE2","title":"Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins","status":"COMPLETED","sponsor":"Richard Chang, M.D.","startDate":"2004-05","conditions":"Acute Deep Venous Thrombosis of the Lower Extremity","enrollment":30},{"nctId":"NCT02120066","phase":"NA","title":"Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm","status":"COMPLETED","sponsor":"Kyorin University","startDate":"2011-01","conditions":"Submacular Hemorrhage, Ruptured Retinal Arterial Macro Aneurysms","enrollment":22},{"nctId":"NCT00061373","phase":"PHASE2","title":"Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2003-05","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT00604695","phase":"PHASE2","title":"A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks","status":"COMPLETED","sponsor":"C. Michael Gibson, MS, MD","startDate":"2008-07","conditions":"Acute Myocardial Infarction","enrollment":40},{"nctId":"NCT00630396","phase":"PHASE1, PHASE2","title":"Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke","status":"COMPLETED","sponsor":"David Hess, MD","startDate":"2008-05","conditions":"Stroke, Acute","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Recombinant Human Tissue Plasminogen Active for Injection"],"phase":"phase_2","status":"active","brandName":"Alteplase for Injection","genericName":"Alteplase for Injection","companyName":"Angde Biotech Pharmaceutical Co., Ltd.","companyId":"angde-biotech-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Alteplase for Injection is a tissue plasminogen activator that works by dissolving blood clots. Used for Ischemic stroke, Acute ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}